ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

RxLogic Unveils SaaS-Based Technology Platform for Pharmacy Benefit Claims at SIIA National Conference 2025, Hosts Break-Out Session, Participates on Panel Presentation

NASHVILLE, Tenn., Oct. 07, 2025 (GLOBE NEWSWIRE) -- RxLogic, a leading technology company for pharmacy benefit claims processing that provides a SaaS-based platform of smart adjudication solutions, announces that the Company will be attending, exhibiting and speaking at the SIIA Innov8 National Conference 2025, October 12–14 in Phoenix, Arizona. Attendees are invited to visit RxLogic at booth #908 with the first 150 visitors receiving a custom ‘Rest Easy’ designed satin pillowcase and the latest SmartBytes newsletter insights. Participants will further understand market opportunities at the session entitled, “Pharma and Payers Working Together” on October 14, 10:15–11:30am MDT in the Grand Sonoran Ballroom E, where Paige Zimmer, EVP, business development, will be speaking on the panel.

Lori Daugherty, CEO, RxLogic, looks forward to welcoming all conference attendees, stating, “We know firsthand the challenges that self-insured stakeholders face with pharmacy claims management and built our flexible, innovative technology platform to deliver control, clarity and results. This modern, SaaS-based platform enables organizations to manage their pharmacy benefits strategy the way that works best for them. RxLogic clients benefit from customizable tools that are designed for real-time claims adjudication, rebate administration, benefit plan customization and integrated financial and clinical tools – all in one modular, cloud-based system. This event is the perfect opportunity to share our vision for smarter, more collaborative solutions.”

Zimmer joins the panel that will explore collaborations to improve patient satisfaction and outcomes, managing costs for specialty pharmaceuticals, cell and gene therapies and GLP-1s. Panelists will also identify financing solutions and discuss emerging opportunities for value-based contracting.

“This session is an opportunity to delve into solutions that enable manufacturers and employers to offer savings directly to employees and offer transparency improvements that help patients benefit from increased access to prescription savings,” says Zimmer. “I will also provide perspectives gained from RxLogic on the role of technology in pharmacy benefits.”

RxLogic continues to drive meaningful change in pharmacy benefit claims adjudication through technology, collaboration and thought leadership. By bringing together industry stakeholders to discuss practical strategies for navigating cost, access and outcomes, RxLogic continues to position itself as a trusted partner for organizations seeking smarter, more sustainable approaches to pharmacy benefit claims processing.

Schedule a time to meet with RxLogic at SIIA here.

About RxLogic, LLC

RxLogic empowers stakeholders across the pharmacy claims ecosystem with SaaS technologies to drive efficiency in pharmacy benefit management. Smart solutions are designed for stakeholders throughout the healthcare ecosystem. Offering full-service claims adjudication, administration, rebate administration, prior authorization solutions, network access and ancillary services, RxLogic is recognized nationwide for its smart technology solutions dedicated client service. Visit www.RxLogic.com 

Media:
Nicholas Turchiano
CPR Marketing
nturchiano@cpronline.com  
201-641-1911x35


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.54
+0.00 (0.00%)
AAPL  274.11
+0.00 (0.00%)
AMD  207.58
+0.00 (0.00%)
BAC  55.33
+0.00 (0.00%)
GOOG  309.32
+0.00 (0.00%)
META  647.51
+0.00 (0.00%)
MSFT  474.82
+0.00 (0.00%)
NVDA  176.29
+0.00 (0.00%)
ORCL  184.92
+0.00 (0.00%)
TSLA  475.31
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.